155 related articles for article (PubMed ID: 24938224)
21. Bioavailability of alpha-linolenic acid in subjects after ingestion of three different forms of flaxseed.
Austria JA; Richard MN; Chahine MN; Edel AL; Malcolmson LJ; Dupasquier CM; Pierce GN
J Am Coll Nutr; 2008 Apr; 27(2):214-21. PubMed ID: 18689552
[TBL] [Abstract][Full Text] [Related]
22. Effect of α-linolenic acid on 24-h ambulatory blood pressure in untreated high-normal and stage I hypertensive subjects.
Pieters DJ; Zock PL; Fuchs D; Mensink RP
Br J Nutr; 2019 Jan; 121(2):155-163. PubMed ID: 30392473
[TBL] [Abstract][Full Text] [Related]
23. Systemic inflammation in morbidly obese subjects: response to oral supplementation with alpha-linolenic acid.
Faintuch J; Horie LM; Barbeiro HV; Barbeiro DF; Soriano FG; Ishida RK; Cecconello I
Obes Surg; 2007 Mar; 17(3):341-7. PubMed ID: 17546842
[TBL] [Abstract][Full Text] [Related]
24. The Salt Swap intervention to reduce salt intake in people with high blood pressure: protocol for a feasibility randomised controlled trial.
Payne Riches S; Piernas C; Aveyard P; Sheppard JP; Rayner M; Jebb SA
Trials; 2019 Oct; 20(1):584. PubMed ID: 31604477
[TBL] [Abstract][Full Text] [Related]
25. Flaxseed in pediatric hyperlipidemia: a placebo-controlled, blinded, randomized clinical trial of dietary flaxseed supplementation for children and adolescents with hypercholesterolemia.
Wong H; Chahal N; Manlhiot C; Niedra E; McCrindle BW
JAMA Pediatr; 2013 Aug; 167(8):708-13. PubMed ID: 23733031
[TBL] [Abstract][Full Text] [Related]
26. Flaxseed on cardiovascular disease markers in healthy menopausal women: a randomized, double-blind, placebo-controlled trial.
Dodin S; Cunnane SC; Mâsse B; Lemay A; Jacques H; Asselin G; Tremblay-Mercier J; Marc I; Lamarche B; Légaré F; Forest JC
Nutrition; 2008 Jan; 24(1):23-30. PubMed ID: 17981439
[TBL] [Abstract][Full Text] [Related]
27. Effects of brown and golden flaxseed on the lipid profile, glycemia, inflammatory biomarkers, blood pressure and body composition in overweight adolescents.
Machado AM; de Paula H; Cardoso LD; Costa NM
Nutrition; 2015 Jan; 31(1):90-6. PubMed ID: 25441591
[TBL] [Abstract][Full Text] [Related]
28. Addition of Propranolol in Resistant Arterial hypertension Treatment (APROPRIATE study): study protocol for a randomized double-blind placebo-controlled trial.
Constantine GR; Ranasinghe P; Weeratunga P; Weeraratne C; Galappatthy P; Rajapakse S; Senarath U; Katulanda P
Trials; 2017 Mar; 18(1):124. PubMed ID: 28292320
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of mHealth and education-led peer counseling for patients with hypertension and coronary artery disease in Pakistan: study protocol for a double-blinded pragmatic randomized-controlled trial with factorial design.
Arshed M; Zakar R; Umer MF; Kiran M; Ullah N; Iftikhar G; Fischer F
Trials; 2023 Jul; 24(1):448. PubMed ID: 37424031
[TBL] [Abstract][Full Text] [Related]
30. Randomised, double-blind, placebo-controlled clinical trial investigating the effects of inorganic nitrate in hypertension-induced target organ damage: protocol of the NITRATE-TOD study in the UK.
Lau CWZ; Hamers AJP; Rathod KS; Shabbir A; Cooper J; Primus CP; Davies C; Mathur A; Moon JC; Kapil V; Ahluwalia A
BMJ Open; 2020 Jan; 10(1):e034399. PubMed ID: 31969369
[TBL] [Abstract][Full Text] [Related]
31. Effect of motivational interviewing in hypertensive patients (MIdNIgHT): study protocol for a randomized controlled trial.
Silveira LCJ; Aliti GB; Da Silva EM; Pimentel RP; Gus M; Rabelo-Silva ER
Trials; 2019 Jul; 20(1):414. PubMed ID: 31288854
[TBL] [Abstract][Full Text] [Related]
32. Impact of weight loss diet associated with flaxseed on inflammatory markers in men with cardiovascular risk factors: a clinical study.
Cassani RS; Fassini PG; Silvah JH; Lima CM; Marchini JS
Nutr J; 2015 Jan; 14():5. PubMed ID: 25577201
[TBL] [Abstract][Full Text] [Related]
33. Effects of Bushen-Jiangya granules on blood pressure and pharmacogenomic evaluation in low-to-medium-risk hypertensive patients: study protocol for a randomized double-blind controlled trial.
Yang X; Liu L; Xiong X; Zhang Y; Liu Y; Li H; Yao K; Wang J
Trials; 2022 Jan; 23(1):37. PubMed ID: 35033168
[TBL] [Abstract][Full Text] [Related]
34. Lowering Effects of n-3 Fatty Acid Supplements on Blood Pressure by Reducing Plasma Angiotensin II in Inner Mongolia Hypertensive Patients: A Double-Blind Randomized Controlled Trial.
Yang B; Shi L; Wang AM; Shi MQ; Li ZH; Zhao F; Guo XJ; Li D
J Agric Food Chem; 2019 Jan; 67(1):184-192. PubMed ID: 30511840
[TBL] [Abstract][Full Text] [Related]
35. No evidence of hypoglycemia or hypotension in older adults during 6 months of flax lignan supplementation in a randomized controlled trial: a safety evaluation.
Billinsky J; Glew RA; Cornish SM; Whiting SJ; Thorpe LU; Alcorn J; Paus-Jenssen L; Hadjistavropoulos T; Chilibeck PD
Pharm Biol; 2013 Jun; 51(6):778-82. PubMed ID: 23577799
[TBL] [Abstract][Full Text] [Related]
36. Twenty weeks of isometric handgrip home training to lower blood pressure in hypertensive older adults: a study protocol for a randomized controlled trial.
Jørgensen MG; Ryg J; Danielsen MB; Madeleine P; Andersen S
Trials; 2018 Feb; 19(1):97. PubMed ID: 29426359
[TBL] [Abstract][Full Text] [Related]
37. Pharmacotherapy for hyperuricemia in hypertensive patients.
Gois PH; Souza ER
Cochrane Database Syst Rev; 2013 Jan; (1):CD008652. PubMed ID: 23440832
[TBL] [Abstract][Full Text] [Related]
38. Comparison of efficacy and safety between benidipine and hydrochlorothiazide in fosinopril-treated hypertensive patients with chronic kidney disease: protocol for a randomised controlled trial.
Xue C; Zhou C; Yang B; Lv J; Dai B; Yu S; Wang Y; Zhao G; Mei C
BMJ Open; 2017 Feb; 7(2):e013672. PubMed ID: 28237959
[TBL] [Abstract][Full Text] [Related]
39. Flaxseed consumption may reduce blood pressure: a systematic review and meta-analysis of controlled trials.
Khalesi S; Irwin C; Schubert M
J Nutr; 2015 Apr; 145(4):758-65. PubMed ID: 25740909
[TBL] [Abstract][Full Text] [Related]
40. Antihypertensive and Renoprotective Effects of Dietary Flaxseed and its Mechanism of Action in Deoxycorticosterone Acetate-Salt Hypertensive Rats.
Watanabe Y; Ohata K; Fukanoki A; Fujimoto N; Matsumoto M; Nessa N; Toba H; Kobara M; Nakata T
Pharmacology; 2020; 105(1-2):54-62. PubMed ID: 31514180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
